Indian drugmakers face squeeze in U.S. healthcare market

MUMBAI (Reuters) - India's small and medium-sized generic drugmakers say the threat of tougher rules and higher barriers for outsiders in the U.S. healthcare market will force many to find a niche or focus their expansion efforts on other countries.